100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting - Metabolism and hormones 2 (2011GENGE1) $26.39
Add to cart

Summary

Samenvatting - Metabolism and hormones 2 (2011GENGE1)

 39 views  4 purchases
  • Module
  • Institution

Samenvatting metabolisme en hormonen 2 - Universiteit Antwerpen nieuw curriculum - vermeld wat belangrijk is voor het examen - behaald resultaat: 19/20

Preview 4 out of 174  pages

  • November 4, 2024
  • 174
  • 2023/2024
  • Summary
avatar-seller
METABOLISME EN
HORMONEN 2




Universiteit Antwerpen
MASTER 1

,INHOUDSOPGAVE

Diabetes mellitus........................................................................................................................................ 6

Diagnose ............................................................................................................................................................... 6

Verschillende typen............................................................................................................................................... 7
Diabetes type I (10%) ........................................................................................................................................ 7
Diabetes type II (85%) ..................................................................................................................................... 10
Andere specifieke types (5%) ......................................................................................................................... 12
Zwangerschapsdiabetes ................................................................................................................................. 13

Acute complicaties .............................................................................................................................................. 13
Acute hypoglycemie ....................................................................................................................................... 13
Acute hyperglycemie ...................................................................................................................................... 16
Hyperglycemische diabetische ketoacidose ............................................................................................... 16
Euglycemische ketoacidose bij SGLT2-inhibitoren ..................................................................................... 19
Hyperosmolair coma (door dehydratatie) .................................................................................................. 19

Chronische complicaties ..................................................................................................................................... 20
Chronische microvasculaire complicaties ...................................................................................................... 20
Retinopathie ............................................................................................................................................... 22
Nefropathie................................................................................................................................................. 23
Neuropathie ................................................................................................................................................ 24
Chronische macrovasculaire complicaties ..................................................................................................... 27
Hartlijden .................................................................................................................................................... 27
Cerebrovasculair lijden ............................................................................................................................... 27
Perifeer vaatlijden ...................................................................................................................................... 27
Behandeling macrovasculaire complicaties ............................................................................................... 27
Overige complicaties ...................................................................................................................................... 28
Huidafwijkingen .......................................................................................................................................... 28
Tandafwijkingen ......................................................................................................................................... 29
Infecties ...................................................................................................................................................... 29

Diabetische voet ................................................................................................................................................. 29
Pathofysiologie ............................................................................................................................................... 29
Diagnose ......................................................................................................................................................... 33
Classificatie ..................................................................................................................................................... 34
Behandeling .................................................................................................................................................... 34
Preventie......................................................................................................................................................... 35

Behandeling ........................................................................................................................................................ 36
Behandeling diabetes type I ........................................................................................................................... 36
Insuline........................................................................................................................................................ 36
Monitoring .................................................................................................................................................. 38
Toediening .................................................................................................................................................. 39
Behandeling diabetes type II .......................................................................................................................... 40
Levensstijl aanpassingen ............................................................................................................................ 40
Orale antidiabetica ..................................................................................................................................... 40
injecties ....................................................................................................................................................... 45

Schildklierpathologie ................................................................................................................................ 48




Metabolisme en hormonen 2 1

, Hyperthyroïdie .................................................................................................................................................... 48
Symptomen..................................................................................................................................................... 48
Diagnose ......................................................................................................................................................... 49
Oorzaken......................................................................................................................................................... 50
Ziekte van Graves-Basedow........................................................................................................................ 50
Toxische multinodulaire goiter ................................................................................................................... 53
Toxisch adenoom ........................................................................................................................................ 54
Thyroïditis ................................................................................................................................................... 55
Medicatie/jodium-geïnduceerde hyperthyroïdie....................................................................................... 58

Hypothyroïdie ..................................................................................................................................................... 59
Symptomen..................................................................................................................................................... 59
Diagnose ......................................................................................................................................................... 60
Behandeling .................................................................................................................................................... 60
Oorzaken......................................................................................................................................................... 61
Ziekte van Hashimoto ................................................................................................................................. 61
Thyroïditis ................................................................................................................................................... 62
Overigen...................................................................................................................................................... 63

Euthyroïdie goiter (= struma).............................................................................................................................. 63
Pathofysiologie ............................................................................................................................................... 64
Differentiaal diagnose .................................................................................................................................... 64
Oorzaken......................................................................................................................................................... 64
Endemische goiter ...................................................................................................................................... 64
Familiale goiter ........................................................................................................................................... 65
Sporadische goiter ...................................................................................................................................... 65
Iatrogene goiter .......................................................................................................................................... 65
Diagnose ......................................................................................................................................................... 66
Behandeling .................................................................................................................................................... 67

Solitaire nodule ................................................................................................................................................... 68
Verschillende typen ........................................................................................................................................ 68
Benigne nodule ........................................................................................................................................... 68
MAligne nodule .......................................................................................................................................... 69
Andere nodules........................................................................................................................................... 69
Diagnose ......................................................................................................................................................... 69
Behandeling .................................................................................................................................................... 70

Schildkliercarcinoom ........................................................................................................................................... 70
Pathofysiologie ............................................................................................................................................... 70
Verschillende typen ........................................................................................................................................ 71
Symptomen..................................................................................................................................................... 72
Diagnose ......................................................................................................................................................... 72
Behandeling .................................................................................................................................................... 74
Prognose ......................................................................................................................................................... 75

Hypofyse pathologie ................................................................................................................................. 76

Adenohypofyse ................................................................................................................................................... 76
Hypofysetumor ............................................................................................................................................... 76
Symptomen................................................................................................................................................. 76
Diagnose ..................................................................................................................................................... 77
Behandeling ................................................................................................................................................ 78


Metabolisme en hormonen 2 2

, Samenvatting aanpak ................................................................................................................................. 79
Hypopituïtarisme ............................................................................................................................................ 79
Oorzaken..................................................................................................................................................... 80
GH deficiëntie ............................................................................................................................................. 81
LH/FSH deficiëntie ...................................................................................................................................... 82
TSH deficiëntie ............................................................................................................................................ 82
ACTH deficiëntie ......................................................................................................................................... 83
PRL deficiëntie ............................................................................................................................................ 83
ADH deficiëntie ........................................................................................................................................... 84
Hypersecretie.................................................................................................................................................. 84
Acromegalie ................................................................................................................................................ 84
Hyperprolactinemie .................................................................................................................................... 87

Neurohypofyse .................................................................................................................................................... 90
Diabetes insipidus ........................................................................................................................................... 90
SIADH (syndrome of inappropriate ADH secretion) ....................................................................................... 92

Beeldvorming ...................................................................................................................................................... 94

Bijnierpathologie ...................................................................................................................................... 95

Bijnierschorsinsufficiëntie ................................................................................................................................... 95
Verschillende vormen ..................................................................................................................................... 95
Oorzaken......................................................................................................................................................... 95
Symptomen..................................................................................................................................................... 97
Diagnose ......................................................................................................................................................... 98
Behandeling .................................................................................................................................................... 99
Prognose ....................................................................................................................................................... 100

Syndroom van Cushing ..................................................................................................................................... 100
Oorzaken....................................................................................................................................................... 101
Symptomen................................................................................................................................................... 102
Diagnose ....................................................................................................................................................... 103
Behandeling .................................................................................................................................................. 105
Prognose ....................................................................................................................................................... 106

Hyperaldosteronisme ........................................................................................................................................ 106
Oorzaken....................................................................................................................................................... 106
Symptomen................................................................................................................................................... 107
Screenen ....................................................................................................................................................... 107
Diagnose ....................................................................................................................................................... 108
Behandeling .................................................................................................................................................. 109

Feochromocytoom ............................................................................................................................................ 109
Regel van 10.................................................................................................................................................. 110
Oorzaken....................................................................................................................................................... 110
Kliniek............................................................................................................................................................ 110
Diagnose ....................................................................................................................................................... 111
Behandeling .................................................................................................................................................. 112

Hyperandrogenemie ......................................................................................................................................... 113
Congenitale bijnierhyperplasie ..................................................................................................................... 113
Bijnierincidentaloom ......................................................................................................................................... 115



Metabolisme en hormonen 2 3

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller poliendekoker. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $26.39. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

51036 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy revision notes and other study material for 15 years now

Start selling

Recently viewed by you


$26.39  4x  sold
  • (0)
Add to cart
Added